Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B.
about
Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Indoleamine 2,3 dioxygenase as ...... tive study with LDH and S100B.
@en
Indoleamine 2,3 dioxygenase as ...... tive study with LDH and S100B.
@nl
type
label
Indoleamine 2,3 dioxygenase as ...... tive study with LDH and S100B.
@en
Indoleamine 2,3 dioxygenase as ...... tive study with LDH and S100B.
@nl
prefLabel
Indoleamine 2,3 dioxygenase as ...... tive study with LDH and S100B.
@en
Indoleamine 2,3 dioxygenase as ...... tive study with LDH and S100B.
@nl
P2093
P2860
P50
P356
P1476
Indoleamine 2,3 dioxygenase as ...... ative study with LDH and S100B
@en
P2093
D Al Kassam
M V de Lecea
P de Llano
P2860
P304
P356
10.1111/JDV.13968
P577
2016-10-10T00:00:00Z